SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-001552
Filing Date
2010-01-11
Accepted
2010-01-11 10:58:00
Documents
8
Period of Report
2010-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c94537e8vk.htm 8-K 21645
2 EXHIBIT 1.1 c94537exv1w1.htm EX-1.1 152236
3 EXHIBIT 4.1 c94537exv4w1.htm EX-4.1 62015
4 EXHIBIT 5.1 c94537exv5w1.htm EX-5.1 10323
5 EXHIBIT 10.1 c94537exv10w1.htm EX-10.1 56264
6 EXHIBIT 99.1 c94537exv99w1.htm EX-99.1 10025
7 GRAPHIC c94537c9453702.gif GRAPHIC 3013
8 GRAPHIC c94537c9453703.gif GRAPHIC 3397
  Complete submission text file 0000950123-10-001552.txt   323336
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 10519352
SIC: 2834 Pharmaceutical Preparations